Literature DB >> 35679923

Evaluating maternal exposure to an environmental per and polyfluoroalkyl substances (PFAS) mixture during pregnancy: Adverse maternal and fetoplacental effects in a New Zealand White (NZW) rabbit model.

Christine E Crute1, Samantha M Hall2, Chelsea D Landon3, Angela Garner4, Jeffrey I Everitt3, Sharon Zhang5, Bevin Blake6, Didrik Olofsson7, Henry Chen8, Susan K Murphy1, Heather M Stapleton2, Liping Feng9.   

Abstract

Mixtures of per- and polyfluoroalkyl substances (PFAS) are often found in drinking water, and serum PFAS are detected in up to 99% of the population. However, very little is known about how exposure to mixtures of PFAS affects maternal and fetal health. The aim of this study was to investigate maternal, fetal, and placental outcomes after preconceptional and gestational exposure to an environmentally relevant PFAS mixture in a New Zealand White (NZW) rabbit model. Dams were exposed via drinking water to control (no detectable PFAS) or a PFAS mixture for 32 days. This mixture was formulated with PFAS to resemble levels measured in tap water from Pittsboro, NC (10 PFAS compounds; total PFAS load = 758.6 ng/L). Maternal, fetal, and placental outcomes were evaluated at necropsy. Thyroid hormones were measured in maternal serum and kit blood. Placental gene expression was evaluated by RNAseq and qPCR. PFAS exposure resulted in higher body weight (p = 0.01), liver (p = 0.01) and kidney (p = 0.01) weights, blood pressure (p = 0.05), and BUN:CRE ratio (p = 0.04) in dams, along with microscopic changes in renal cortices. Fetal weight, measures, and histopathology were unchanged, but a significant interaction between dose and sex was detected in the fetal: placental weight ratio (p = 0.036). Placental macroscopic changes were present in PFAS-exposed dams. Dam serum showed lower T4 and a higher T3:T4 ratio, although not statistically significant. RNAseq revealed that 11 of the 14 differentially expressed genes (adj. p < 0.1) are involved in placentation or pregnancy complications. In summary, exposure elicited maternal weight gain and signs of hypertension, renal injury, sex-specific changes in placental response, and differential expression of genes involved in placentation and preeclampsia. Importantly, these are the first results to show adverse maternal and placental effects of an environmentally-relevant PFAS mixture in vivo.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  PFAS mixture; Per- and polyfluoroalkyl substances (PFAS); Placental and birth outcomes; Rabbit

Mesh:

Substances:

Year:  2022        PMID: 35679923      PMCID: PMC9374364          DOI: 10.1016/j.scitotenv.2022.156499

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   10.753


  134 in total

1.  Perfluorohexane Sulfonate (PFHxS) and a Mixture of Endocrine Disrupters Reduce Thyroxine Levels and Cause Antiandrogenic Effects in Rats.

Authors:  Louise Ramhøj; Ulla Hass; Julie Boberg; Martin Scholze; Sofie Christiansen; Flemming Nielsen; Marta Axelstad
Journal:  Toxicol Sci       Date:  2018-06-01       Impact factor: 4.849

2.  High trans-placental transfer of perfluoroalkyl substances alternatives in the matched maternal-cord blood serum: Evidence from a birth cohort study.

Authors:  Dan Cai; Qing-Qing Li; Chu Chu; Shi-Zhong Wang; Ye-Tao Tang; Allison A Appleton; Rong-Liang Qiu; Bo-Yi Yang; Li-Wen Hu; Guang-Hui Dong; Xiao-Wen Zeng
Journal:  Sci Total Environ       Date:  2019-12-02       Impact factor: 7.963

3.  Absorption, distribution, and excretion of ammonium perfluorooctanoate (APFO) after oral administration to various species.

Authors:  S G Hundley; A M Sarrif; G L Kennedy
Journal:  Drug Chem Toxicol       Date:  2006       Impact factor: 3.356

4.  Per- and polyfluoroalkyl substances (PFAS) augment adipogenesis and shift the proteome in murine 3T3-L1 adipocytes.

Authors:  Seyed Mohamad Sadegh Modaresi; Wei Wei; Marques Emily; Nicholas A DaSilva; Angela L Slitt
Journal:  Toxicology       Date:  2021-11-17       Impact factor: 4.221

5.  Identifying Risk Factors for Levels of Per- and Polyfluoroalkyl Substances (PFAS) in the Placenta in a High-Risk Pregnancy Cohort in North Carolina.

Authors:  Jacqueline Bangma; Lauren A Eaves; Kirsi Oldenburg; Jessica L Reiner; Tracy Manuck; Rebecca C Fry
Journal:  Environ Sci Technol       Date:  2020-06-12       Impact factor: 9.028

6.  Depuration kinetics and tissue disposition of PFOA and PFOS in white leghorn chickens (Gallus gallus) administered by subcutaneous implantation.

Authors:  Hoon Yoo; Keerthi S Guruge; Noriko Yamanaka; Chihiro Sato; Osamu Mikami; Shigeru Miyazaki; Nobuyoshi Yamashita; John P Giesy
Journal:  Ecotoxicol Environ Saf       Date:  2007-11-19       Impact factor: 6.291

7.  Disposition of perfluorinated acid isomers in Sprague-Dawley rats; part 1: single dose.

Authors:  Jonathan P Benskin; Amila O De Silva; Leah J Martin; Gilles Arsenault; Robert McCrindle; Nicole Riddell; Scott A Mabury; Jonathan W Martin
Journal:  Environ Toxicol Chem       Date:  2008-10-21       Impact factor: 3.742

8.  Exposure to perfluoroalkyl substances in early pregnancy and risk of sporadic first trimester miscarriage.

Authors:  Sverre Wikström; Ghada Hussein; Annika Lingroth Karlsson; Christian H Lindh; Carl-Gustaf Bornehag
Journal:  Sci Rep       Date:  2021-02-11       Impact factor: 4.379

Review 9.  Thyroid Disrupting Effects of Old and New Generation PFAS.

Authors:  Francesca Coperchini; Laura Croce; Gianluca Ricci; Flavia Magri; Mario Rotondi; Marcello Imbriani; Luca Chiovato
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-19       Impact factor: 5.555

10.  Elevated levels of per- and polyfluoroalkyl substances in Cape Fear River Striped Bass (Morone saxatilis) are associated with biomarkers of altered immune and liver function.

Authors:  T C Guillette; James McCord; Matthew Guillette; M E Polera; Kyle T Rachels; Clint Morgeson; Nadine Kotlarz; Detlef R U Knappe; Benjamin J Reading; Mark Strynar; Scott M Belcher
Journal:  Environ Int       Date:  2020-02-07       Impact factor: 9.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.